Immunotherapy for humans
US7521040B2 · kind B2 · utility
0Cited by
6References
1Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Mar 19, 2007 |
| Grant date | Apr 21, 2009 |
| Priority date | — |
| Expiry date | May 5, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An immunotherapy useful for treating a cancer and/or treating and preventing a microbial infection is provided.A pharmaceutical composition which comprises a bacterial component as an effective ingredient is disclosed, which is used for immunotherapy in a patient suffering from a cancer or microbial infection, wherein the immunotherapy comprises eradicating the cancer cells or the microorganisms from the lymph nodes of the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.